Q-omics provides the consensus-scored LINC00240 profile across patient tissues and cancer cell-line models. LINC00240 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, LINC00240 is differentially expressed in 11, with the highest sampling consensus in KIRC. Additionally, LINC00240 RNA expression shows 16,503 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight LUAD, KIRC, and THYM as cancer lineages where LINC00240 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00240 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00240 survival associations across molecular data types. LINC00240 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00240 RNA expression–survival associations across cancer types. High LINC00240 expression shows favorable associations in LUAD, UVM, READ, OV, CESC and BLCA. The LUAD Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for LINC00240 RNA expression.
This table summarizes LINC00240 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00240. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00240 shows lower tumor expression in KICH and THCA and higher tumor expression in KIRC, HNSC, KIRP and LIHC. The KIRC box plot shows higher LINC00240 RNA expression in tumor versus normal tissue (log2 FC = +0.996, t-test p < 0.001).
This table shows molecular features associated with LINC00240 in patient tissues and cancer cell lines. In patient samples, LINC00240 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
